| SKU | ISG007517 |
| Brand | Vesicare |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 10 Mg |
| Shop by Concerns | Incontinence |
| Gender | Unisex |
| Shop By Goals | Bladder Control |
| Ingredient | Solifenacin succinate 10 mg |
| UPC | 8718692510180 |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Kidney Medications |
| Warning | Avoid in urinary retention or uncontrolled narrow-angle glaucoma Caution in Liver or Kidney Impairment May cause dry mouth Use under medical supervision |
Vesicare 10 Mg
Description:
Vesicare 10 mg (solifenacin succinate) is a prescription oral medicine used for the treatment of overactive bladder. It belongs to the class of antimuscarinic agents and works by relaxing the smooth muscles of the bladder, helping to increase bladder capacity and reduce involuntary bladder contractions. Vesicare 10 mg film-coated tablets are indicated for adults who experience symptoms such as strong sudden urges to urinate, frequent urination, and urge urinary incontinence. This product is intended for medical use under the supervision of a healthcare professional.
Indications:
- Treatment of overactive bladder in adults.
- Management of urge urinary incontinence (involuntary leakage of urine associated with a sudden, strong urge to urinate).
- Reduction of urinary urgency (sudden compelling desire to pass urine that is difficult to defer).
- Reduction of urinary frequency (need to urinate more often than usual during the day and/or night).
Active Ingredients / Key Components:
- Solifenacin succinate – equivalent to 10 mg solifenacin per film-coated tablet.
- Other inactive ingredients (excipients) are present in the tablet formulation; detailed excipient list is not available in the provided information.
Dosage & Administration / How to Use:
- Standard adult dose: 10 mg solifenacin (one Vesicare 10 mg film-coated tablet) taken once daily, or as directed by the prescribing physician.
- Tablets should be swallowed whole with a glass of water; do not crush or chew.
- Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
- In some patients (e.g., those with moderate liver or kidney impairment or taking certain interacting medicines), the doctor may prescribe a lower dose (such as 5 mg) instead of 10 mg.
- Do not exceed the prescribed dose or change the dose without consulting your doctor.
- If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
- Use regularly as prescribed to achieve optimal control of overactive bladder symptoms; treatment duration is determined by the physician based on response and tolerability.
Clinical Benefits:
- Helps reduce episodes of urge urinary incontinence, decreasing involuntary urine leakage.
- Decreases urinary urgency, allowing better control over the need to urinate.
- Reduces urinary frequency, helping patients urinate less often during the day and night.
- Improves bladder capacity by relaxing bladder smooth muscle, allowing the bladder to hold more urine.
- Enhances quality of life, social confidence, and daily functioning for patients with overactive bladder.
Warnings & Contraindications:
- Contraindicated in patients with urinary retention, severe gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity to solifenacin succinate or any component of the formulation.
- Use with caution in patients with clinically significant bladder outflow obstruction, gastrointestinal obstructive disorders, decreased gastrointestinal motility, severe constipation, or risk of urinary retention.
- Use with caution in patients with hepatic or renal impairment; dose adjustment may be required as determined by the physician.
- May cause blurred vision, dizziness, or drowsiness; avoid driving or operating machinery if affected.
- Use with caution in patients with autonomic neuropathy, hiatal hernia, gastroesophageal reflux disease, or those taking medications that can cause or worsen these conditions.
- Drug interactions may occur with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, itraconazole); dose adjustment or alternative therapy may be necessary.
- Consult your doctor before use if pregnant or planning pregnancy. Use in pregnancy only if clearly needed and prescribed by a physician.
- It is not known if solifenacin is excreted in human breast milk; breastfeeding women should consult their doctor before use.
- Not recommended for use in children and adolescents unless specifically prescribed by a specialist (safety and efficacy data are limited in pediatric populations).
- Consult your doctor before use if you have liver disease, kidney disease, glaucoma, myasthenia gravis, or any chronic medical condition.
- Keep out of reach of children.
- Not intended to diagnose, treat, cure, or prevent any disease without medical supervision; it is a prescription medicine that must be used under a doctor’s guidance.
Side Effects:
- Common side effects: dry mouth, constipation, blurred vision, nausea, dyspepsia (indigestion), abdominal pain, dry eyes, and urinary tract infections.
- Other possible side effects: dizziness, fatigue, headache, dry skin, palpitations, increased heart rate (tachycardia), and difficulty in urination.
- Serious side effects (seek immediate medical attention): severe allergic reactions (rash, itching, swelling of face/lips/tongue, difficulty breathing), severe constipation, signs of urinary retention (inability to pass urine), confusion, or hallucinations.
- If any side effects are severe, persistent, or concerning, stop taking the medicine and contact your doctor or pharmacist promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the outer carton to protect from light. Do not store above the temperature specified on the package (typically below 25°c, if stated on the original pack). Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack.
Specifications:
- Product type: Prescription medicine for overactive bladder.
- Active ingredient strength: solifenacin succinate equivalent to 10 mg solifenacin per film-coated tablet.
- Form: Film-coated tablets.
- Pack size: 30 film-coated tablets per pack (30 f.c. tabs.).
- Route of administration: Oral.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
